Synthesis, spectroscopic characterization and biological application of copper complex of 5-carbethoxy-2-thiouracil
Abstract
5-carbethoxy-2-thiouracil (eitotH2) reacts with CuX (X= Cl, Br, I) halides to give the formula [CuX(eitotH)2]2 dinuclear complexes, while the formula [CuX(PPh3)2(eitotH)2] mononuclear mixed ligand complexes result when reaction is carried out in the presence of two equivalent of triphenylphosphine (PPh3). The new copper (I) complexes were studied against two tumor cell lines, A549 (human pulmonary carcinoma cell line) and HeLa (human epithelial carcinoma cell line) and one regular immortalized cell line, MRC5 (human fetal lung fibroblast). In comparison to the phosphine free ones that hindered cell proliferation only at relatively high concentration, the mixed ligand complexes with triphenylphosphine were found to be extremely cytotoxic.
Keywords: Copper (I), 5-carbethoxy-2-thiouracil (eitotH2), Triphenylphosphine, in vitro cytotoxicity, carcinoma cell lines
Keywords:
Copper (I), 5-carbethoxy-2-thiouracil (eitotH2), Triphenylphosphine, in vitro cytotoxicity, carcinoma cell linesDOI
https://doi.org/10.22270/jddt.v10i6.4417References
Kaim W, Rall J, Copper, a “modern bioelement”, Angewandte Chemie International Edition English 1996; 35:43–60.
Solomon E.I., Sundaram U.M., Mechonkin T.E., Multicopper Oxidases and Oxygenases, Chemical Reviews 1996; 96:2563–2605.
Holland P.L., Tolman W.B., Dioxygen activation by copper sites: relative stability and reactivity of (μ-η2:η2-peroxo)- and bis(μ-oxo)dicopper cores, Coordination Chemistry Reviews 1999; 190–192:855–869.
Liang H.-C., Dahan M., Karlin K.D., Dioxygen-activating bio-inorganic model complexes, Current Opinion in Chemical Biology 1999; 2:168–175.
González-Álvarez M., G. Alzuet, J. Borrás, S. García-Granda, J.M. Montejo-Bernardo, Structural and functional models for the dinuclear copper active site in catechol oxidases Synthesis, X-ray crystal structures, magnetic and spectroscopic properties of μ-methoxobridged dinuclear copper(II) complexes with N-substituted sulfonamide ligands, Journal of Inorganic Biochemistry 2003; 96:443–451.
Chohan Z.H., Pervez H., Rauf A., Scozzafava A., Supuran C.T., Antibacterial Co(II), Cu(II), Ni(II) and Zn(II) complexes of thiadiazole derived furanyl, thiophenyl and pyrrolyl Schiff bases, Journal of Enzyme Inhibition and Medicinal Chemistry 2002; 17:117–122.
Sau D.K., R.J. Butcher, S. Chaudhuri, N. Saha, Spectroscopic, structural and antibacterial properties of copper(II) complexes with bio-relevant 5-methyl-3-formylpyrazole N(4)-benzyl-N(4)-methylthiosemicarbazone, Molecular and Cellular Biochemistry 2003; 253:21–29.
Tsiaggali M., E.G. Andreadou, A.G. Hatzidimitriou, A.A. Pantazaki, P. Aslanidis, Copper(I) halide complexes of N-methylbenzothiazole-2-thione: Synthesis, structure, luminescence,antibacterial activity and interaction with DNA, Journal of Inorganic Biochemistry 2013; 121:121–128.
Weder J.E., C.T. Dillon. T.W. Hambley, B.J. Kennedy, P.A. Lay, J.R. Biffin, H.L. Regtop, N.M. Davies, Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized, Coordination Chemistry Reviews 2002; 232:95–126.
Moya-Hernández M.R., A. Mederos, S. Domínguez, A. Orlandini, C.A. Ghilardi, F. Cecconi,E. González-Vergara, A. Rojas-Hernández, Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)2(py)2]•EtOH, Journal of Inorganic Biochemistry 2003; 95:131–140.
Hindi K.M., M.J. Panzer, C.A. Tessier, C.L. Cannon, W.J. Youngs, The Medicinal Applications of Imidazolium Carbene−Metal Complexes, Chemical Reviews 2009; 109:3859–3884.
Bowen R.J., M. Navarro, A.M. Shearwood, P.C. Healy, B.W. Skelton, A. Filipovska, S.J.Berners-Preis, 1:2 Adducts of copper(I) halides with 1,2-bis(di-2-pyridylphosphino)ethane: solid state and solution structural studies and antitumour activity, Daltonon Transactions 2009; 10861–10870.
F. Tisato, C. Marzano, M. Porchia, M. Pellei, C. Santini, Copper in diseases and treatments, and copper-based anticancer strategies, Medicinal Research Reviews 2010; 30:708–749.
Marzano C, Pellei M, Tisato F, Santini C, Copper Complexes as Anticancer Agents, Anti-Cancer Agents in Medicinal Chemistry 2009; 9:165–211.
Reich K.A., L.E. Marshall, D.R. Graham, D.S. Sigman, Cleavage of DNA by the 1,10-phenanthroline-copper ion complex. Superoxide mediates the reaction dependent on NADH and hydrogen peroxide, Journal of the American Chemical Society 1981; 103:3582–3584.
Sigman D.S., Nuclease activity of 1,10-phenanthroline-copper ion, Accounts of Chemical Research 1986; 19:180–186.
Sigman D.S., Mazumder A, Perrin D.M., Chemical nucleases, Chemical Reviews 1993; 93.
Lieberman I, Kornberg A, Simms E.S., Enzymatic synthesis of pyrimidine nucleotides.Orotidine-5'-phosphate and uridine-5'-phosphate, Journal of Biological Chemistry 1955; 215:403–415.
Victor J, Greenberg L.B., Sloan D.L., Studies of the kinetic mechanism of orotate phosphoribosyltransferase from yeast, Journal of Biological Chemistry 1979; 254:2647–2655.
Dodin G, Dubois JE, Tautomerism of Orotic Acid Dianion. Effect of Calcium and Magnesium Cations on the Tautomeric Constant and on Tautomerization Dynamics, Journal of the American Chemical Society 1980; 102:3049–3056.
Arrizabalaga P, Castan P. Dahan F, Coordination sites of 5-nitro-6-carboxyuracil: UV study and x-ray structure determination of diammine(5-nitroorotato)copper(II) hydrate and hexaamminebis(5-nitroorotato)tricopper(II) pentahydrate, Inorganic Chemistry 1983; 22:2245–2252.
Arrizabalaga P, Castan P. J.-P. Laurent, Intramolecular influence of a carboxylic function on platinum blue synthesis. A systematic study of complexes originating from acid amides, Journal of the American Chemical Society 1984; 106:4814–4818.
Lea M.A., A. Luke, A. Assad, M. Patel, P. Amala Reddy, Inhibitory action of orotate, 2-thioorotate and isoorotate on nucleotide metabolism and nucleic acid synthesis in hepatoma cells, International Journal of Biochemistry 1992; 24:1453–1459.
Garoufis A., S.K. Hadjikakou, N. Hadjiliadis, Palladium coordination compounds as antiviral,anti-fungal, anti-microbial and anti-tumor agents, Coordination Chemistry Reviews 2009; 253:1384–1397.
Hueso-Urena F., M.N. Moreno-Carretero, J.M. Salas-Peregrin, G.Alvarez de Cienfuegos-Lopez, Palladium, platinum, cadmium, and mercury complexes with neutral isoorotic and 2-thioisoorotic acids: IR and NMR spectroscopies, thermal behavior and biological properties, Journal of Inorganic Biochemistry 1991; 43:17–27.
Hueso-Urena F., M.N. Moreno-Carretero, J.M. Salas-Peregrin, C. Valenzuela-Calahorro,G.Alvarez de Cienfuegos-Lopez, Thermal, spectral and biological studies or metal complexes of isoorotic and 2-thioisoorotic acids, Thermochimica Acta 1988; 133:341–346.
Rosenberg B., L. Van Camp, R.G. Fisher, S. Kansy, H.J. Peresie, J.R. Davidson, U.S. Patent No. 4,419,351, 1983.
Lea M.A., Luke A, Assad A, Patel M, Reddy PA, Inhibitory action of orotate, 2-thioorotate and isoorotate on nucleotide metabolism and nucleic acid synthesis in hepatoma cells, International Journal of Biochemistry 1992; 24:1453–1459.
Kutal C., Spectroscopic and photochemical properties of d10 metal complexes, Coordination Chemistry Reviews 1990; 99:213–252.
Sharma A., Gupra V, Mishra R, Tandon P, S. Maeda, K.-K. Kunimoto, Study of vibrational spectra and molecular structure of intermolecular hydrogen bonded 2-thiohydantoin using Density Functional Theory, Journal of Molecular Structure 2011; 1004:237–252.
Mosmann T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of Immunological Methods 1983; 65:55–63.
Porchia M., Dolmella A., V. Gandin, C. Marzano, M. Pellei, V. Peruzzo, F. Fefosco, C.Santini, F. Tisato, Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity, Journal of Medicinal Chemistry 2013; 59:218–226.
Griffith D., J.P. Parker, C.J. Marmion, Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics, Anti-Cancer Agents in Medicinal Chemistry 2010; 10:354–370.
Berners-Price S.J., Sadler P.J., Phosphines and metal phosphine complexes: relationship of chemistry to anticancer and other biological activity, in: Structure and Bonding, Springer, Berlin, 1988.
Nazarov A.A., Dyson P.J., Metal Phosphorus Complexes as Antitumor Agents, in: Phosphorus Compounds, Catalysis by Metal Complexes, 37, Springer Science+Business Media B.V., 2011.
Tiekink E.R.T., Gold derivatives for the treatment of cancer, Critical Reviews inOncology/Hematology 2002; 42:225–248.
Adams J., Development of the Proteasome Inhibitor PS-34, Oncologist 2002; 7:9–16.
Dou Q.P., Goldfarb R.H., Bortezomib/PS341 (millennium pharmaceuticals), IDrugs 2002; 5:828–834.
Published
Abstract Display: 348 
PDF Downloads: 314 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.